INHD · Inno Holdings Inc.

The thesis

Inno Holdings' shares remain a low-conviction recovery case that rests on reported cash of $33,238,616 at 30 June 2026, and the fiscal 2026 annual report (Form 10-K) is the first audited test of it. The shares closed at $4.07 on 28 October 2026 (adjusted daily closes), up from $3.94 on 15 October 2026 and still 99.2% below the adjusted 52-week high of $528.00.

The narrative is dead: SEC EDGAR lists no filing after the Form 4 dated 11 September 2026, and the three-month price change is negative 77.4%. The 14-day relative strength index (RSI) has eased to 55.7 from 72.8 on 15 October 2026, so the short-term surge has cooled without a drop in price.

The balance-sheet evidence is still the quarterly report for 30 June 2026, filed 18 August 2026. September cash and the current share count are not disclosed. Nothing has appeared since the prior note to raise or lower confidence in the cash claim.

Bullish and bearish views on Inno Holdings Inc.

The bull case on Inno Holdings Inc. (INHD), in brief: Reported cash is large against the shares. The bear case: No company news supports the price.

Bull case

• Reported cash is large against the shares. The Form 10-Q showed cash of $33,238,616 and stockholders' equity of $55,634,839 at 30 June 2026. Whether that converts into a per-share floor depends on the audited share count, which is not yet filed.
• Operating losses narrowed. Nine-month revenue was $4,456,054 against $1,760,350 a year earlier. Net loss fell to $2,720,214 from $5,505,169 (10-Q filed 18 August 2026).
• The shares have held above the September low. The adjusted close was $3.05 on 18 September 2026 and $4.07 on 28 October 2026. The close has stayed above $3.94 across the two most recent readings (15 October 2026 and 28 October 2026).

Bear case

• No company news supports the price. SEC EDGAR lists no 8-K, 10-K or other filing after 11 September 2026. The most recent 8-K was filed 31 August 2026.
• Share issuance can dilute the cash claim. The company collected $5,435,576 in July 2026 under a $60 million at-the-market equity program with Aegis Capital Corp (10-Q, 18 August 2026). No later issuance total is public.
• Finance leadership is in flux before the audit. Mengshu Shao left as director and chief financial officer effective 25 August 2026, and Mei Wang is interim (Form 8-K filed 31 August 2026).
• Governance questions are open. A board special committee formed on 8 June 2026 to review trading around the price spike. No filing located through 28 October 2026 reports its conclusions.
• The shares remain far below their highs. The three-month change of negative 77.4% (to 28 October 2026) shows how far the June spike has reversed. Two reverse splits in about six months sit inside the adjusted history.

Price setup

The adjusted close was $4.07 on 28 October 2026. The 18 September 2026 close of $3.05 is the recent low, and the 4 September 2026 close of $4.53 is the nearest recent higher close. The adjusted 52-week high comes from a series with two reverse splits in about six months, so long-range percentages overstate how much of the loss reached holders at any one time.

Crowding evidence is limited to price. The 14-day RSI of 55.7 on 28 October 2026 compares with 72.8 on 15 October 2026, so momentum has cooled. No analyst coverage or insider purchase explains the rebound from the September low. The at-the-market program is the main supply risk, since sales can occur into strength without advance notice.

The fiscal 2026 annual report falls due after the 30-day window. Until it is filed, the price has no new company disclosure to anchor it, and a daily close below $3.05 would put the shares under the September low.

Catalysts, next 30 days

No company event is scheduled inside the next 30 days. The company has not announced a quarterly report, and fiscal year-end was 30 September 2026.

• ~29 December 2026 (est.): fiscal 2026 annual report (Form 10-K). This is the filing deadline for a non-accelerated filer, 90 days after year-end. It would be the first audited statement of cash, share count and at-the-market issuance. A late-filing notice (Form NT 10-K) would be an adverse signal.

Elapsed catalysts

• Any time: an 8-K on the special committee, the permanent chief financial officer or at-the-market sales. None is scheduled, and none has been filed since 31 August 2026. (passed 67d ago)

What would change the view

The case breaks if the audited annual report restates the 30 June 2026 cash balance of $33,238,616, shows a share count well above the 2,520,662 shares outstanding after the May 2026 reverse split, or carries an auditor qualification. A late-filing notice, an auditor change or a disclosed finding from the special committee would also weaken it.

On price, a daily close below $3.05, the 18 September 2026 close and the recent low in adjusted closes, ends the recovery reading. Confidence would rise on an on-time 10-K that confirms the cash balance with no further dilution disclosed.

What it trades with

No current theme carries this name, and the shares trade on company-specific events: the reverse splits, the 8 June 2026 trading halt and its 31 July 2026 end, and the at-the-market program. Moves in the broader market or in other small-cap names have not been tied to its price in any filing or news report found. The micro-cap size and thin disclosure make the price sensitive to any single filing.